Details for 2019886683

Up to date per 12.04.2026

Actions

Title / Product Name

KOMBINATIONSTHERAPIE, EINSCHLIESSLICH EINES KRAS-G12C-INHIBITORS UND EINES ODER MEHRERER ZUSÄTZLICHER PHARMAZEUTISCHER WIRKSTOFFE FÜR DIE BEHANDLUNG VON KREBS

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2019886683

EP Publication Number

3883579

E-Number

1870144

Language

PCT Number

US19062064

Publication Date

29.09.2021 A

24.12.2025 B1

Registration Date

24.12.2025

AT Publication Date

15.01.2026

Application Date

18.11.2019

Registration Number

Priorities

19.11.2018

201862769355 P

20.03.2019

201962821376 P

24.06.2019

201962865819 P

IPC

A61K 31/555 20060101AFI20210527BHEP

Maximum Duration of Protection

18.11.2039

Owner

Amgen Inc.One Amgen Center Drive Thousand Oaks CA 91320US

Representative

No representatives present

Inventor

LIPFORD, James RussellOne Amgen Center Drive Legal Dept - Patent Operations MS 28-5-A Thousand Oaks, CA 91320-1799US

CANON, Jude RobertOne Amgen Center Drive Legal Dept - Patent Operations MS 28-5-A Thousand Oaks, CA 91320-1799US

SAIKI, Anne Y.One Amgen Center Drive Legal Dept - Patent Operations MS 28-5-A Thousand Oaks, CA 91320-1799US

REX, Karen LouiseOne Amgen Center Drive Legal Dept - Patent Operations MS 28-5-A Thousand Oaks, CA 91320-1799US

Information about Fees